Product News and Recalls

Blog: $1.2b J&J fine for Risperdal deceptive marketing likely to cause further problems

A post on stock market information Website Seeking Alpha says Johnson & Johnson will likely deal with significant public backlash going forward. An Arkansas jury recently concluded that the company used deceptive tactics to market antipsychotic drug Risperdal, which included hiding or minimizing the drug’s risks. A judge then issued a $1.2 billion fine.

The post says the fine leveled against Johnson and Johnson and subsidiary Janssen Pharmaceuticals is the largest ...

continue reading...

Psychiatrist details deceptive tactics for SSRI clinical trials

In a piece published in British newspaper The Daily Mail, psychiatrist David Healy claims pharmaceutical companies commonly use deceptive tactics to manipulate clinical trials for new drugs. As a result, Healy alleges, health regulatory agencies approve drugs that are not only ineffective, but dangerous for patients who use them.

He writes that the corporate tactics include the following:

  • Conducting clinical trials and not publishing any negative results that come out of ...
continue reading...

FDA defends medical device approval process

An internal document from the U.S. Food and Drug Administration defends the agency’s rejection of European standards for approving medical devices, according to a report in the Minneapolis-St. Paul Star Tribune.

The FDA document amounts to the agency’s defense of its own practices, and describes 12 classes of allegedly “unsafe and ineffective” high-risk medical devices approved for sale in Europe but not the United States.

According to the Star Tribune, the United ...

continue reading...

Report links depression to stroke risk

A CNN report says that depression is a risk factor for stroke, although a relatively minor one.

The report cites research published in the Journal of the American Medical Association, which suggests that as many as 4 percent of the estimated 795,000 strokes that occur in the United States each year can be attributed to depression.

Lead researcher An Pan, Ph.D., said the depression might add to stroke risk because people with ...

continue reading...

Antidepressants ineffective in treating autism symptoms

An article published in the journal Pediatrics claims that “publication bias,” or medical journals’ tendency to publish clinical trials with a positive result, may have given physicians the false impression that certain types of antidepressants improve repetitive behaviors in autistic children such as rocking and hand-flapping.

A report on the research in U.S. News and World Report says analysis of all the studies, not just the ones that made it into ...

continue reading...

Surgeons association concerned about hip implants

The American Society of Orthopaedic Surgeons held an expert roundtable on the subject of metal-on-metal hips at the organization’s annual meeting in San Francisco, which took place in February.

The devices, which feature both a ball and socket coated in metal, have generated thousands of lawsuits nationally over both their high early failure rate, and their tendency to produce toxic metal ...

continue reading...
Page 354 of 386 «...330340350352353354355356...»